These data provided the evidence of LTBP1 to be a potential bridge linking depressive/anxiety disorder and GBM, and laid the foundation for further therapy targeting LTBP1 for treating GBM patients who showed symptoms of depression/anxiety. The gene discussed is LTBP1; the disease is anxiety disorder.